Autoimmune and Inflammatory Immunomodulators Market 2023
Factors such as the rising adoption of TNF-alpha inhibitors & B-cell inhibitors, increasing development of novel therapies, increasing chronic diseases such as HIV, cancer, & arthritis, rising geriatric population, and advancements in technology drive the market growth. In addition, a large number of clinical trials and innovative R&D approaches fuel the market growth. However, adverse effects of these drugs and alternative drug therapies are expected to restrain the market growth. The Autoimmune and Inflammatory Immunomodulators Market in emerging nations is...
View full press release